Cart (0 Items)
Your cart is currently empty.
View ProductsVesencumab Biosimilar – Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Vesencumab Biosimilar - Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb - Research Grade |
|---|---|
| Source | CAS 1205533-60-3 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Vesencumab,MNRP1685A,Neuropilin-1, NRP1, VEGF165R extracellular domain ,anti-Neuropilin-1, NRP1, VEGF165R extracellular domain |
| Reference | PX-TA1266 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Vesencumab Biosimilar - Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain mAb - Research Grade
General information on Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain [Homo sapiens] (Vesencumab) Monoclonal Antibody
Vesencumab is investigated for the treatment of Locally Advanced or Metastatic Solid Tumors.
Related products
Antigen
Neuropilin-1 recombinant protein
PX-P5210 385€
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
PTX17885 180€
SIL
Reviews
Il n’y a pas encore d’avis.